Davenport-Mugar Cancer Center

Oncology

Doctor David R. Lovett, MD works in the field of Oncology. He researched medicine at University of Massachusetts Medical School. University of Massachusetts Medical School is ranked 49 in research and 12 in primary care medicine He has 1 awards "Regional Top Doctor". David R. Lovett, MD is a published MD. He has 3 papers published. The most current publication "Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias." He accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• Thalidomide and rituximab in Waldenstrom macroglobulinemia.
• Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid Leukemias.
• A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma.

Schools

---

• University of Massachusetts Worcester Campus

• Worcester Meml Hospital

• Meml Sloan Kettering Canc C

Procedures Preformed

---

• Thoracentesis

Conditions Treated

---

• Acute Leukemia
• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• View All

Doctors Specialties

---

• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• Regional Top Doctor

Education

---

• Memorial Sloan-Kettering Cancer Center
• University of Massachusetts Medical School

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Mercedes Lindsey, MD This Doctor is OpenDoctor Recommended.
	Dr. Henry R. Casey Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Harvey W. Neitlich, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Monica E. Smith, MD This Doctor is OpenDoctor Recommended.
	Dr. Allen D. Ward, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog